# Microbiotix, Inc.

Canonical: https://abierto.us/vendors/microbiotix-inc-scnkbdm341t1

- UEI: SCNKBDM341T1
- CAGE: 465F8
- Location: Worcester, MA
- Awards in window: 2 (4 transactions), $3,787,586 obligated, June 18, 2026 to August 26, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $3,787,586

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $3,787,586

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75N93023C00001 (definitive contract): $3,787,586, National Institutes of Health Niaid. EO14398 to Develop the PPZ Series of Small Molecule Pan-Filovirus Entry Inhibitors Through Lead Optimization, Selection of a Preclinical Candidate, and Ind-Enabling Preclinical Studies.. https://www.usaspending.gov/award/CONT_AWD_75N93023C00001_7529_-NONE-_-NONE-/
- 75N93020C00019 (definitive contract): $0, National Institutes of Health Niaid. To Develop Phenoxyacetamide T3SS Inhibitors as Adjunctive Agents to Antibacterial Therapy for MDR P. Aeruginosa Infections.. https://www.usaspending.gov/award/CONT_AWD_75N93020C00019_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/microbiotix-inc-scnkbdm341t1.